EASL-ILC 2021 - International Liver Congress of the European Association for the Study of the Liver (Virtual Meeting)
Jun 23 - Jun 26, 2021 | AmsterdamNetherlands
LARVOL is not affiliated with International Liver Congress of the European Association for the Study of the Liver (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Showing 104 abstracts linked to Trials
OS-295 - [VIRTUAL] Checkmate 040 Cohort 5: long-term efficacy and safety of nivolumab in patients with Child-Pugh B advanced hepatocellular carcinoma and associations between baseline biomarker analyses and outcomes
GS-945 - [VIRTUAL] Radiological and pathological response to neoadjuvant Nivolumab in patients with BCLC A HCC treated by curative percutaneous irreversible electroporation: preliminary report from the NIVOLEP trial (NCT03630640)
OS-1145 - [VIRTUAL] A phase Ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): PETAL
OS-1399 - [VIRTUAL] Results of the therapetuic cancer vaccine HepaVac-101 clinical trial in HCC patients
OS-1674 - [VIRTUAL] IMbrave150: exploratory efficacy and safety results of atezolizumab + bevacizumab vs sorafenib in patients with unresectable hepatocellular carcinoma (HCC) who had prior locoregional therapy (LRT)
OS-2679 - [VIRTUAL] Hepatic arterial infusion chemotherapy in combination with PD-1 inhibitor as conversion therapy in locally advanced, potentially resectable hepatocellular carcinoma: A phase II study
PO-1236 - [VIRTUAL] Beta-blockers to prevent decompensation of cirrhosis: an emulation of the PREDESCI trial
PO-2403 - [VIRTUAL] A single assessment of acute hemodynamic response to intravenous propranolol predicts hepatic decompensation in cirrhotic patients with portal hypertension
PO-675 - [VIRTUAL] Increased incidence of respiratory failure with terlipressin use in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure
OS-845 - [VIRTUAL] Treatment of hepatorenal syndrome type 1 with terlipressin reduces need for renal replacement therapy post-liver transplantation
PO-968 - [VIRTUAL] Terlipressin improves renal replacement therapy-free survival in hepatorenal syndrome type 1
OS-2142 - [VIRTUAL] COMPARISON OF 20% ALBUMIN VERSUS CRYSTALLOID PLASMALYTE FOR FLUID RESUSCITATION IN CIRRHOTICS WITH SEPSIS INDUCED HYPOTENSION AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL
OS-513 - [VIRTUAL] Algorithm combining fat-free muscle index and total spontaneous portosystemic shunt area indentifies high-risk cirrhotic patients
PO-1930 - [VIRTUAL] Albumin dysfunction correlates with disease markers in patients with decompensated cirrhosis
PO-1643 - [VIRTUAL] Nutritional supplementation with B-Hydroxy-B-methylbutyrate (HMB) in malnourished cirrhotic patients